Biomeme and Indical bring mobile diagnostics solutions to animal health & food production sectors through exclusive partnership

May 20, 2019

Biomeme and Indical enters into an exclusive global licensing and research agreement in a joint effort to improve animal health globally.

Biomeme has developed an advanced mobile PCR detection technology that solves time-sensitive and location-sensitive problems where results need to be in real-time. Indical, with twenty years of experience animal diagnostics, will adapt the molecular point-of-need testing for veterinary applications and offer its suite of molecular and immunological testing solutions.

Read more about the exclusive partnership here.

Recent news

Fidelio Capital acquires Premune’s shares in Ne…

We are pleased to announce that, effective 24 November 2020, Fidelio Capital AB (“Fidelio”) has completed the acquisition of Premune AB’s (“Premune”) shares in Nextmune. Through the transaction, Fidelio will increase its ownership in Nextmune and become the majority owner.

Read more

Indical acquires Afosa to expand into the compani…

Indical has acquired Afosa GmbH, a leading provider of ELISA diagnostics products to the companion animal sector, based in Germany. Indical has a strong diagnostics portfolio focused on production animals, which is built on more than twenty years of research

Read more

BoNea and Akevo join Nabo

Nabo acquires BoNea and Akevo – two property management companies based in Sweden. BoNea and Akevo offer financial management services to 250 tenant-owner associations. Read the full press release here (Swedish).

Read more